No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Drug Delivery Systems*
-
Humans
-
Neuroendocrine Tumors / drug therapy*
-
Neuroendocrine Tumors / physiopathology